drugset / Trial / NCT00311155

Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension

NCT00311155

Phase 4 Completed 694 enrolled Sankyo Pharma Gmbh
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This study is to assess the safety and efficacy of an add-on treatment algorithm with olmesartan, hydrochlorothiazide and amlodipine in patients with mild to moderate hypertension.

Timeline

Start
2006-03
Primary completion
2008-04
Completion
2008-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg Oral
Subject Hydrochlorothiazide Unknown 25 mg Oral
Subject Olmesartan medoxomil Unknown 20 mg Oral